Literature DB >> 33438082

Acute lymphoid leukemia etiopathogenesis.

Thiago Cezar Fujita1, Nathália Sousa-Pereira1, Marla Karine Amarante2, Maria Angelica Ehara Watanabe1.   

Abstract

Acute lymphoid leukemia (ALL) is a type of hematological neoplasm that affects the precursor cells of strains B, T  and NK, with a higher incidence in the pediatric range. The pathophysiology of ALL is characterized by chromosomal abnormalities and genetic alterations involved in the differentiation and proliferation of lymphoid precursor cells. Despite the lack of information in the literature, it is believed that leukemogenesis originates from a complex interaction between environmental and genetic factors, which combined lead to cellular modifications. Environmental factors have been evaluated as possible predisposing factors in the development of ALL but there are still conflicting results in the world literature. In this context, the aim of the present review is to discuss the major exogenous factors regarding ALL.

Entities:  

Keywords:  Childhood; Environment; Infection; Leukemia

Mesh:

Substances:

Year:  2021        PMID: 33438082     DOI: 10.1007/s11033-020-06073-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  68 in total

Review 1.  Biology of acute lymphoblastic leukemia (ALL): clinical and therapeutic relevance.

Authors:  Carlos Graux
Journal:  Transfus Apher Sci       Date:  2011-02-25       Impact factor: 1.764

Review 2.  Leukemia stem cells and microenvironment: biology and therapeutic targeting.

Authors:  Marina Y Konopleva; Craig T Jordan
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

Review 3.  Bone marrow neoplastic niche in leukemia.

Authors:  Shirin Azizidoost; Sadegh Babashah; Fakher Rahim; Mohammad Shahjahani; Najmaldin Saki
Journal:  Hematology       Date:  2013-11-25       Impact factor: 2.269

4.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

Review 5.  Acute lymphoblastic leukaemia.

Authors:  Florent Malard; Mohamad Mohty
Journal:  Lancet       Date:  2020-04-04       Impact factor: 79.321

Review 6.  Acute lymphoblastic leukaemia.

Authors:  Ching-Hon Pui; Leslie L Robison; A Thomas Look
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321

Review 7.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

Review 8.  Acute lymphoblastic leukemia and lymphoblastic lymphoma in adolescents and young adults.

Authors:  Jennifer L McNeer; Archie Bleyer
Journal:  Pediatr Blood Cancer       Date:  2018-02-08       Impact factor: 3.167

9.  Work-related leukemia: a systematic review.

Authors:  Ioannis Polychronakis; George Dounias; Vasilios Makropoulos; Elena Riza; Athena Linos
Journal:  J Occup Med Toxicol       Date:  2013-05-22       Impact factor: 2.646

Review 10.  Risk factors for acute leukemia in children: a review.

Authors:  Martin Belson; Beverely Kingsley; Adrianne Holmes
Journal:  Environ Health Perspect       Date:  2007-01       Impact factor: 9.031

View more
  2 in total

1.  Explainable AI in Diagnosing and Anticipating Leukemia Using Transfer Learning Method.

Authors:  Wahidul Hasan Abir; Md Fahim Uddin; Faria Rahman Khanam; Tahia Tazin; Mohammad Monirujjaman Khan; Mehedi Masud; Sultan Aljahdali
Journal:  Comput Intell Neurosci       Date:  2022-04-27

2.  The characteristics and prognostic significance of the SET-CAN/NUP214 fusion gene in hematological malignancies: A systematic review.

Authors:  Jing Wang; Qian-Ru Zhan; Xiao-Xuan Lu; Li-Jun Zhang; Xiao-Xue Wang; He-Yang Zhang
Journal:  Medicine (Baltimore)       Date:  2022-07-29       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.